HMGB-1 as an inflammatory cytokine, potential target of novel anti-inflammatory therapy?;Prozapalne właściwości HMGB-1 - Potencjalny cel przyszłej terapii przeciwzapalnej?

Alergia Astma Immunologia

Volumn 13, Issue 1, 2008, Pages 16-22

  Nocuń, Marek ^a   Pałczyński, Cezary ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

HMGB; Inflammation; Proinflammatory cytokines; TNF

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

CELL DAMAGE; CELL DEATH; CELL SURFACE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNE SYSTEM; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW;

EID: 46749156257     PISSN: 14273101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Ferrari S, Finelli P, Rocchi M i wsp. The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. Genomics 1996; 35: 367-71.
2. Parrish W, Ulloa L High-mobility group box-1 isoforms as potential therapeutic targets in sepsis. Methods Mol Biol 2007; 361: 145-62.
3. Weir HM, Kraulis PJ, Hill CS i wsp. Structure of the HMG box motif in the B-domain of HMG1. EMBO J 1993; 12: 1311-9.
4. Kuehl L, Salmond B, Tran L Concentrations of high-mobility-group proteins in the nucleus and cytoplasm of several rat tissues. J Cell Biol 1984; 99: 648-54.
5. Muller S, Bianchi ME, Knapp S Thermodynamics of HMGB1 interaction with duplex DNA. Biochemistry 2001; 40: 10254-61.
6. Thomas JO HMG1 and 2: architectural DNA-binding proteins. Biochem Soc Trans 2001; 29 (Pt 4): 395-401.
7. Calogero S, Grassi F, Aguzzi A i wsp. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet 1999; 22: 276-80.
8. Melvin VS, Edwards DP Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2. Steroids 1999; 64: 576-86.
9. Wang H, Bloom O, Zhang M i wsp. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-51.
10. Li J, Kokkola R, Tabibzadeh S i wsp. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med 2003; 9: 37-45.
11. Scaffidi P, Misteli T, Bianchi ME Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-5.
12. Tang D, Shi Y, Kang R i wsp. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 2007; 81: 741-7.
13. Rouhiainen A, Kuja-Panula J, Wilkman E i wsp. Regulation of monocyte migration by amphoterin (HMGB1). Blood 2004; 104: 1174-82.
14. El Gazzar M HMGB1 modulates inflammatory responses in LPS-activated macrophages. Inflamm Res 2007; 56: 162-7.
15. Wang H, Vishnubhakat JM, Bloom O i wsp. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999; 126: 389-92.
16. Charoonpatrapong K, Shah R, Robling AG i wsp. HMGB1 expression and release by bone cells. J Cell Physiol 2006; 207: 480-490.
17. Semino C, Ceccarelli J, Lotti LV i wsp. The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion. J Leukoc Biol 2007; 81: 92-9.
18. Faraco G, Fossati S, Bianchi ME i wsp. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem 2007; 103: 590-603.
19. Mullins GE, Sunden-Cullberg J, JohanssonAS i wsp. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand J Immunol 2004; 60: 566-73.
20. Dumitriu IE, Baruah P, Bianchi ME i wsp. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur J Immunol 2005; 35: 2184-90.
21. Ito I, Fukazawa J, Yoshida M Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J Biol Chem 2007; 282: 16336-44.
22. Jiang W, Pisetsky DS The role of IFN-alpha and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide. J Immunol 2006; 177: 3337-43.
23. Gardella S, Andrei C, Ferrera D i wsp. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002; 3: 995-1001.
24. Bonaldi T, Talamo F, Scaffidi P i wsp. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003; 22: 5551-60.
25. Youn JH, Shin JS Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 2006; 177: 7889-97.
26. Li J, Qu X, Schmidt AM Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells. J Biol Chem 1998; 273: 30870-8.
27. Yu M, Wang H, Ding A i wsp. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006; 26: 174-9.
28. Park JS, Svetkauskaite D, He Q i wsp. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279: 7370-7.
29. Hori O, Brett J, Slattery T i wsp. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995; 270: 25752-61.
30. Huttunen HJ, Fages C, Kuja-Panula J i wsp. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 2002; 62: 4805-11.
31. Taniguchi N, Kawahara K, Yone K i wsp. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 2003; 48: 971-81.
32. Fiuza C, Bustin M, Talwar S i wsp. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003; 101: 2652-60.
33. Kokkola R, Andersson A, Mullins G i wsp. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005; 61: 1-9.
34. Park JS, Gamboni-Robertson F, He Q i wsp. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006; 290: C917-24.
35. Merenmies J, Pihlaskari R, Laitinen J i wsp. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem 1991; 266: 16722-9.
36. Salmivirta M, Rauvala H, Elenius K i wsp. Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res 1992; 200: 444-51.
37. Huttunen HJ, Fages C, Rauvala H Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999; 274: 19919-24.
38. Park JS, Arcaroli J, Yum HK i wsp. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003; 284: C870-9.
39. Renard P, Raes M The proinflammatory transcription factor NFkappaB: a potential target for novel therapeutical strategies. Cell Biol Toxicol 1999; 15: 341-1.
40. Andersson U, Wang H, Palmblad K i wsp. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192: 565-70.
41. Abraham E, Arcaroli J, Carmody A i wsp. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000; 165: 2950-4.
42. DeMarco RA, Fink MP, Lotze MT Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1. Mol Immunol 2005; 42: 433-44.
43. Messmer D, Yang H, Telusma G i wsp. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 2004; 173: 307-13.
44. Yang D, Chen Q, Yang H i wsp. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 2007; 81: 59-66.
45. Treutiger CJ, Mullins GE, Johansson AS i wsp. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 2003; 254: 375-85.
46. Degryse B, Bonaldi T, Scaffidi P i wsp. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001; 152: 1197-206.
47. Yang H, Ochani M, Li J i wsp. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 2004; 101: 296-301.
48. Ren D, Sun R, Wang S Role of inducible nitric oxide synthase expressed by alveolar macrophages in high mobility group box 1 - induced acute lung injury. Inflamm Res 2006; 55: 207-15.
49. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A i wsp. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 2005; 33: 564-73.
50. Suda K, Kitagawa Y, Ozawa S i wsp. Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis. World J Surg 2006; 30: 1755-62.
51. Ulloa L, Ochani M, Yang H i wsp. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A 2002; 99: 12351-6.
52. Goldstein RS, Bruchfeld A Yang L i wsp. Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 2007; 13: 210-5.
53. Kokkola R, Li J, Sundberg E i wsp. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 2003; 48: 2052-8.
54. Ek M, Popovic K, Harris HE i wsp. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 2006; 54: 2289-94.
55. Popovic K, Ek M, Espinosa A i wsp. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 2005; 52: 3639-45.
56. Sobajima J, Ozaki S, Uesugi H i wsp. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut 1999; 44: 867-73.
57. Agnello D, Wang H, Yang H i wsp. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 2002; 18: 231-6.
58. Takata K, Kitamura Y, Tsuchiya D i wsp. High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicity. J Neurosci Res 2004; 78: 880-91.
59. Maeda S, Hikiba Y, Shibata W i wsp. Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer. Biochem Biophys Res Commun 2007; 360: 394-400.
60. Akaike H, Kono K, Sugai H i wsp. Expression of high mobility-group box chromosomal protein-1 (HMGB-1) in gastric cancer Anticancer Res 2007; 27: 449-57.
61. Lotze MT, DeMarco RA Dealing with death: HMGB1 as a novel target for cancer therapy. Curr Opin Investig Drugs 2003; 4: 1405-9.
62. Alleva LM, Yang H, Tracey KJ i wsp. High mobility group box 1 (HMGB1) protein: possible amplification signal in the pathogenesis of falciparum malaria. Trans R Soc Trop Med Hyg 2005; 99: 171-4.
63. Goldstein RS, Gallowitsch-Puerta M, Yang L i wsp. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 2006; 25: 5714.
64. Taira T, Matsuyama W, Mitsuyama H i wsp. Increased serum high mobility group box-1 level in Churg-Strauss syndrome. Clin Exp Immunol 2007; 148: 241-7.
65. Yasuda T, Ueda T, Takeyama Y i wsp. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas 2006; 33: 359-63.
66. Nowak P, Barqasho B, Sonnerborg A Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infection. AIDS 2007; 21: 869-71.
67. Kalinina N, Agrotis A, Antropova Y i wsp. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 2004; 24: 2320-5.
68. Hatada T, Wada H, Nobori T i wsp. Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost 2005; 94: 975-9.